Position in ALVO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$0
-$4,404 QoQ
Shares Held
24,165
+1782.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WOLVERINE ASSET MANAGEMENT LLC holds $11,280,730 across 7 Drug Manufacturers - Specialty & Generic names. ALVO ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
251,619 | $8,723,630 | |
| 2 | EBS |
Emergent BioSolutions Inc.
|
174,933 | $1,465,938 | |
| 3 | PRGO |
PERRIGO Co plc
|
61,551 | $639,514 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
73,094 | $360,353 | |
| 5 | ZTS |
Zoetis Inc.
|
1,270 | $91,262 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1 | $33 | |
| 7 | ALVO |
Alvotech
This page
|
24,165 | $0 |
All Filings in ALVO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,404 | 1,284 | Shares | Defined | 2026-05-04 | |
| 2025-09-30 | $188,902 | 23,065 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $219,135 | 24,028 | Shares | Defined | 2025-08-04 | |
| 2025-03-31 | $89,795 | 9,286 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $98,537 | 7,448 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $69,507 | 5,841 | Shares | Defined | 2024-11-04 | |
| 2023-12-31 | $71,485 | 6,227 | Shares | Defined | 2024-02-01 | |
| 2023-09-30 | $162,855 | 17,857 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $137,532 | 17,769 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $30,650 | 2,376 | Shares | Defined | 2023-05-08 | |
| No filing history on record for this holder in this stock. | ||||||